LEILA MILLER: Open Payments
NPI 1568746139 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 27 payments from 9 companies in 2025. Trend: 2023 $689 · 2024 $703 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 12 | $249 |
| GENZYME CORPORATION | 3 | $103 |
| Janssen Biotech, Inc. | 3 | $65 |
| ABBVIE INC. | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Medtronic, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| UCB, Inc. | 1 | $14 |
Products named: NUCALA, DUPIXENT, TREMFYA, RINVOQ, LIBTAYO, PROPEL, Bimzelx.
Industry payments across VA — which companies pay providers there.
